Skip to content
★ Sign in to follow
JA

Jason Aryeh

Aralez Pharmaceuticals Inc.
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€369k

Latest filing published 13 Jun 2017 for Aralez Pharmaceuticals Inc., €53k.

Filing timeline

BuySale
Jason Aryeh

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

No signal scores available.

Jason Aryeh: trading record in brief

Jason Aryeh appears in our data through filings on Aralez Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 5 February 2016 to 23 May 2017, the count stands at 4 filings.

Sales make up the whole of the open-market record (3 sales, €369k). Since January 2017: no purchases and 3 sales on the market.

The latest filing, published on 13 June 2017, reports an open-market sale of €53k in Aralez Pharmaceuticals Inc. Typically, a trade is published a median of 22 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jason Aryeh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▼
    8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of IssuerExecutivesAralez Pharmaceuticals Inc.
    79,558 CAD0SEDI
    51,041 shares@ CA$1.5587Common SharesTSXSEDI:3021239
  • ▼
    8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of IssuerExecutivesAralez Pharmaceuticals Inc.
    332,365 CAD0SEDI
    233,468 shares@ CA$1.4236Common SharesTSXSEDI:3021240
  • ▼
    8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of IssuerExecutivesAralez Pharmaceuticals Inc.
    146,878 CAD0SEDI
    104,176 shares@ CA$1.4099Common SharesTSXSEDI:3021241
  • ●
    8 - Deemed Insider - 6 Months before becoming Insider, 4 - Director of IssuerExecutivesAralez Pharmaceuticals Inc.
    0SEDI
    Common SharesTSXSEDI:2787583

4 of 4 declarations